|
Bioident Executive to speak at the Printed Electronics Conference
English Version 89.83 Kb
Menlo Park, California – November 14, 2007
Wasiq Bokhari, CEO of BIOIDENT Technologies, will discuss the role of Printed Electronics for Life Sciences at the Printed Electronics Conference taking place November 12-15, 2007 in San Francisco, Calif. Recognized for his pioneering work in printed sensor applications for life science markets, Bokhari has a wealth of experience bringing technology developments to market.
In this session, Bokhari will provide a short overview on printed electronics and BIOIDENT’s potential applications in the life sciences sector. Bokhari will also discuss the advantages of using printed electronics for devices and in the production process, as well as provide several real-world examples.
Location:
Carnelian Room
555 California Street, 52nd Floor
San Francisco, CA 94104
Date/Time:
Wednesday, November 14, 2007
10:00-10:30 a.m. PT
This is the fourth annual Printed Electronics USA conference and exhibition that covers all the applications, technologies and opportunities. This conference remains America’s largest event on printed and thin film electronics. With more than 50 exhibitors and 500 delegates anticipated, the whole industry will be at this event.
About Wasiq Bokhari
Bokhari is a co-founder and managing partner of Quantum Insight. He works with Fortune 500 companies on the adoption and commercialization of materials and nanotechnology with applications in energy, IT and medicine. Bokhari also works with entrepreneurs and early-stage startups in technology commercialization.
He is a serial entrepreneur with extensive experience in the field of emerging materials and nanotechnology. He serves as a strategic advisor to Chevron and is part of the team that has built and grown Molecular Diamond Technologies, a new nanomaterials focused business unit. He also serves as a strategic advisor to Hitachi in the areas of emerging electronics, energy and life sciences applications. Bokhari was part of the founding team and interim CEO of Kalinex Inc., a drug discovery instrumentation company. Prior to that, he was part of the founding team and Senior Vice President of Products of Clickmarks, an enterprise infrastructure software company, subsequently acquired by Semotus Solutions.
Bokhari received his Ph.D. in physics from the Massachusetts Institute of Technology, under Nobel Laureate Jerome Friedman. He was part of the team that discovered a fundamental particle called the top quark at the Fermi National Accelerator Laboratory in 1995. He is an author of more than 50 scientific and technical publications, and is cited as an inventor on eight patents, granted and applied. He is also the co-founder and Steering Committee Chair of the MIT Stanford UC Berkeley Nanotechnology Forum. Bokhari has worked with PCAST (Presidential Council of Advisors on Science and Technology) on issues related to energy. PCAST is the highest civilian body that advises the US President on issues in science and technology.
About BIOIDENT Technologies Inc.
BIOIDENT is the leader in the development of rapid, multi-assay and mobile analytical and diagnostic systems. BIOIDENT integrates highly sensitive printed photodetectors and electronics with various existing Lab-on-a-Chip (LOC) technologies including lateral flow, microfluidics and microarrays. BIOIDENT’s systems are designed for applications in in-vitro diagnostics, chemical and biological threat detection, and environmental testing. BIOIDENT’s award-winning Photonic Lab™ Technology Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays. Benefits for BIOIDENT’s customers and partners include high mobility, rapid testing, multiplexing and low cost of ownership.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG, the world leader in printed opto-electronics. The company is privately held with headquarters in Menlo Park, California. BIOIDENT leverages NANOIDENT’s SEMICONDUCTOR 2.0™ Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer. NANOIDENT also has the world’s only dedicated organic fabrication facility with a production output of 40,000 sq.m per year. For more information about the company, please visit www.bioident.com or www.nanoident.com
|
